TrioBP Biomarker composition for diagnosis of glioma comprising TRIO and F-actin-binding protein

摘要

The present invention relates to a biomarker composition for diagnosing glioma, comprising TrioBP, and a diagnostic composition, diagnostic kit, a method for providing information on glioma diagnosis, a method for screening a glioma therapeutic agent, and a pharmaceutical composition for preventing or treating glioma. . TrioBP of the present invention is overexpressed in glioma cells, and the effect of inhibiting cell proliferation and migration through the inhibition of the TrioBP is remarkably excellent, it is possible to diagnose glioma by targeting TrioBP as well as nerves using its inhibitor It is also available for screening, prophylaxis or treatment of glioma, which can be useful in related pharmaceutical and medical projects.